GUIDE | Diabetes:
2024 9th Edition of GUIDE: Upgrading Diabetes Management Practices, Raising Awareness and Knowledge leverage DHC Solution to improve patients’ outcomes.
2-3 May
for our Scientific Meeting on'
2024 9th Edition of GUIDE: Upgrading Diabetes Management Practices, Raising Awareness and Knowledge leverage DHC Solution to improve patients'
Agenda - Day 1
Session I | ||||
Time | Topic | Speakers | Chairpersons | |
18:30 - 18:35 | Opening & Guide program introduction | Khalifa Abdallah | Atef Bassiony Khalifa Abdallah Nabil Elnaggar |
|
18:35 - 18:50 | National Health Insurance in Egypt & Diabetes "Achievements & Records" |
Reham Medhat | ||
18:50 - 19:10 | Clinical inertia & unmet needs in glycemic control | Mohamed Abdel Raouf | ||
19:10 - 19:30 | Diabetes management options | Nabil Elkafrawy | ||
19:30 - 19:40 | Discussion | |||
Session II Sanofi Industrial Symposium |
||||
Time | Topic | Speakers | Chairpersons | |
19:40 - 20:00 | Follow the target "cruciality of effective titration" | Hala Kahla | Khalifa Abdallah Nabil Elkafrawy Nabil Elnaggar |
|
20:00 - 20:20 | Make it simple & effective "once for simplicity & Power" | Nouran Elghandour | ||
20:20 - 20:25 | Introducing Daleel | Khalifa Abdallah | ||
20:25 - 20:30 | Digital healthcare Solution & insulin connectivity | Ehab Shaarawy | ||
20:30 - 20:35 | Soliqua add Value | Khaled Abdel Nasser |
Agenda - Day 2
Session I | |||
Time | Topic | Speakers | Chairpersons |
18:30 - 18:50 | Diabetes Guidelines 2024 | Mohamed Reda Halawa | Khalifa Abdallah Ibtissam Zakaria Sherif Hafez |
18:50 - 19:10 | Simaltanueas Vs Sequential approach | Khalifa Abdallah | |
19:10 - 19:20 | Discussion | ||
Session II Sanofi Industrial Symposium |
|||
Time | Topic | Speakers | Chairpersons |
19:20 - 19:40 | Comparison of I-Glarlixi to other intensification option - unmet needs "I-Glarlixi Vs Complex insulin regimen" |
Yehia Ghanem | Ibrahim Elebrashy Mohamed Khattab Nermine Sheriba |
19:40 - 20:00 | Evidence based choices on the path to basal insulin for patients uncontrolled on premixed insulin | Hesham Elgayar |